JP2025124655A5 - - Google Patents
Info
- Publication number
- JP2025124655A5 JP2025124655A5 JP2025076885A JP2025076885A JP2025124655A5 JP 2025124655 A5 JP2025124655 A5 JP 2025124655A5 JP 2025076885 A JP2025076885 A JP 2025076885A JP 2025076885 A JP2025076885 A JP 2025076885A JP 2025124655 A5 JP2025124655 A5 JP 2025124655A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- new products
- manufacturing methods
- manufacturing
- methods substantially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19184680.7 | 2019-07-05 | ||
| EP19184680 | 2019-07-05 | ||
| EP20170224.8 | 2020-04-17 | ||
| EP20170224 | 2020-04-17 | ||
| PCT/GB2020/051592 WO2021005338A2 (en) | 2019-07-05 | 2020-07-03 | Novel cancer antigens and methods |
| JP2022500119A JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500119A Division JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025124655A JP2025124655A (ja) | 2025-08-26 |
| JP2025124655A5 true JP2025124655A5 (enExample) | 2025-09-30 |
Family
ID=71523190
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500119A Active JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
| JP2025076885A Pending JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500119A Active JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220213159A1 (enExample) |
| EP (1) | EP3993826A2 (enExample) |
| JP (2) | JP7751817B2 (enExample) |
| KR (1) | KR20220034040A (enExample) |
| CN (1) | CN114206913A (enExample) |
| AU (1) | AU2020309202A1 (enExample) |
| BR (1) | BR112022000020A2 (enExample) |
| CA (1) | CA3142329A1 (enExample) |
| IL (1) | IL289335A (enExample) |
| MX (1) | MX2022000263A (enExample) |
| WO (1) | WO2021005338A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7712207B2 (ja) | 2018-10-19 | 2025-07-23 | ザ フランシス クリック インスティチュート リミティッド | 新規な癌抗原及び方法 |
| JP2023522198A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 黒色腫を治療するためのｃｔｌ抗原の融合タンパク質 |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0871747A1 (en) | 1996-01-02 | 1998-10-21 | Chiron Viagene, Inc. | Immunostimulation mediated by gene-modified dendritic cells |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| EP1586330A1 (en) * | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| EP1871391B1 (en) | 2005-03-30 | 2011-12-28 | Viroxis | Endogenous retrovirus and proteins encoded by env as a target for cancer treatment |
| WO2006105642A1 (en) * | 2005-04-05 | 2006-10-12 | British Columbia Cancer Agency | Biomarkers for the detection of lung cancer and uses thereof |
| AT502292B1 (de) * | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| WO2007137279A2 (en) | 2006-05-22 | 2007-11-29 | Board Of Regents, The University Of Texas System | Herv-k antigens, antibodies, and methods |
| EP2160406B1 (en) * | 2007-05-24 | 2013-10-02 | Baxter Healthcare SA | Antibodies useful for therapy and diagnosis of cancer |
| EP2751288A4 (en) * | 2011-08-30 | 2015-09-30 | Nat Defense Medical Ct | GENE BIOMARKERS FOR PREDICTING SENSITIVITY TO EGG TREE NEOPLASMS AND / OR FORECASTING THE MALIGNITY OF EGG CANCER |
| EA202091134A1 (ru) * | 2017-12-28 | 2020-11-20 | Кодиак Байосайенсес, Инк. | Экзосомы для иммуноонкологической и противовоспалительной терапии |
| JP2023522198A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 黒色腫を治療するためのｃｔｌ抗原の融合タンパク質 |
-
2020
- 2020-07-03 WO PCT/GB2020/051592 patent/WO2021005338A2/en not_active Ceased
- 2020-07-03 BR BR112022000020A patent/BR112022000020A2/pt not_active IP Right Cessation
- 2020-07-03 EP EP20737269.9A patent/EP3993826A2/en active Pending
- 2020-07-03 MX MX2022000263A patent/MX2022000263A/es unknown
- 2020-07-03 JP JP2022500119A patent/JP7751817B2/ja active Active
- 2020-07-03 CA CA3142329A patent/CA3142329A1/en active Pending
- 2020-07-03 CN CN202080049314.4A patent/CN114206913A/zh active Pending
- 2020-07-03 AU AU2020309202A patent/AU2020309202A1/en not_active Abandoned
- 2020-07-03 KR KR1020217040819A patent/KR20220034040A/ko active Pending
-
2021
- 2021-12-17 US US17/644,938 patent/US20220213159A1/en active Pending
- 2021-12-23 IL IL289335A patent/IL289335A/en unknown
-
2025
- 2025-05-02 JP JP2025076885A patent/JP2025124655A/ja active Pending